Search results
Vaccine makers receive stock boost after third human bird flu case in US
Newsweek· 6 days agoShares in some companies that produce vaccines have seen stock boosts following a small number of...
Director-General’s Award for Global Health goes to Prime Minister of Barbados and developers of mRNA...
World Health Organization· 2 days agoWHO Director-General Dr Tedros Adhanom Ghebreyesus presented his Award for Global Health to the...
Explainer-What are the FLiRT COVID variants and are they more contagious? By Reuters
Investing.com· 5 days agoThe moniker FLiRT is an acronym for the locations of the mutations the variants share on the virus'...
Moderna Was Among The Best Performing Large-Cap Stocks Last Week (May 20-May 26, 2024): Are They In...
Benzinga· 3 days agoAre they in your portfolio? First Solar, Inc. FSLR shares jumped 41.5% possibly in response to...
The Heroes Of Vaccine Development: Lipid Nanoparticles
BioresearchOnline· 4 days agoLipid nanoparticles (LNPs) have played a crucial role in the advancement of vaccine development,...
mRNA Vaccines vs. the Pandemic
The North Coast Journal· 7 days ago"I knew that [mRNA] can be used for everything and I had a kind of a Cassandra feeling, that I can see the future and nobody believes me." About 13...
‘Cloaked’ proteins deliver cancer-killing therapeutics into cells | Cornell Chronicle
Cornell News Service· 2 days agoAn interdisciplinary collaboration has designed a way to “cloak” proteins so that they can be...
New approach uses 'cloaked' proteins to deliver cancer-killing therapeutics into cells
Phys.org· 1 day agoThe generalizable technique could lead to repurposing thousands of commercial protein products, including antibodies, for biological research and therapeutic applications. The group's paper, ...
Vaccine Stocks Rise on Growing Threat of Bird Flu Infections
Zacks· 7 days agoFree Report) and Pfizer (PFE Quick QuotePFE - Free Report) to set up a possible vaccine program aimed at preventing the spread of the H5N1 virus, also known as bird flu, in humans. Both these ...
Medigene AG Expands its End-to-End Platform by Submitting Three Development Optimization Technology...
Benzinga· 2 days agoPlanegg/Martinsried, May 28, 2024 – Medigene AG (Medigene or the "Company", FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid